Blog
-
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery
Published : 08/05/2026Authors: Mathieu Repellin et al. Source: Journal of Controlled Release. They demonstrated that muscle cells are not just passive recipients but vital antigen-producing...
-
Distinct antigen presentation drives potent T cell immunity in mRNA-LNP vaccines
Published : 07/29/2026Authors: Ryunosuke Muro et al. Source: Science Advances. They identified an unconventional antigen presentation pathway driven by migratory type 2...
-
Development of a gene-activated matrix for enhanced AAV gene delivery in vitro
Published : 07/21/2026New publication that concretizes the work carried out on the development of AAVBlast during the EU-funded SBR grant.
-
Inhibition of pathogenic tau signaling by novel small molecules
Published : 07/01/2026Authors: Nowar R et al. Source: Front. Pharmacol. They identified a series of novel small-molecule inhibitors that target a specific toxic region of the tau protein...
-
Stem cell mRNA transfection: LNP delivery Application Note
Published : 06/25/2026Evaluate NanOZ-LNP Stem for efficient mRNA delivery to primary human CD34+ stem cells. Data on transfection efficiency, viability, and phenotype preservation.
-
Adamtsl3 regulates perineuronal net and adult cortical plasticity
Published : 06/17/2026Authors: Cramer, T.M.L., Hannan, S.B., Petre, L. et al. Source: Mol Psychiatry. They identified Adamtsl3 as a crucial regulator of perineuronal nets...
-
Human corticospinal connectoid model for post-injury axon regrowth
Published : 06/10/2026Authors: Gibbons G, Fuchsberger T, Abdelgawad M et al. Source: Cell Reports. They developed a groundbreaking 3D “connectoid” platform..
-
Webinar: LNP Platform, from ionizable lipid design to custom & targeted delivery
Published : 06/03/2026Join us for a session covering LNP design principles, proprietary ionizable lipids, quality control, and comprehensive in vitro & in vivo performance data..





